Results 31 to 40 of about 470,158 (371)

Pharmacogenetics of ophthalmic topical β-blockers [PDF]

, 2008
Glaucoma is the second leading cause of blindness worldwide. The primary glaucoma risk factor is elevated intraocular pressure. Topical β-blockers are affordable and widely used to lower intraocular pressure.
McCarty, Catherine A., Patchett, Richard, Sidjanin, Duska J., Smith, Edward M., Wilke, Russell A.   +4 more
core   +1 more source

Efficacy and Tolerability of a New Latanoprost 0.005% BAK-Free Nanoemulsion: A Nonrandomized Open-Label Trial

Re:GEN Open, 2021
Purpose: To assess the effectiveness and tolerability of a new latanoprost 0.005% benzalkonium chloride (BAK)-free nanoemulsion. Methods: A nonrandomized multicenter study was conducted between January 2017 and October 2017 in 15 ophthalmological ...
Javier F. Casiraghi, Daniel Grigera, J. Alejo Peyret, Melina del Papa, Mar?a Silvia Passerini   +4 more
doaj   +1 more source

Efficacy and safety of XEN 45 gel stent alone or in combination with phacoemulsification in advanced open angle glaucoma patients: 1-year retrospective study [PDF]

International Journal of Ophthalmology, 2020
AIM: To assess the effectiveness of the XEN 45 gel stent, either alone or combined with cataract surgery, in advanced stage open angle glaucoma (OAG) patients.
Teresa Laborda-Guirao, Juan M Cubero-Parra, Antonio Hidalgo-Torres   +2 more
doaj   +1 more source

Adapted motivational interviewing to improve the uptake of treatment for glaucoma in Nigeria: study protocol for a randomized controlled trial. [PDF]

, 2014
BACKGROUND: Glaucoma is a chronic eye disease associated with irreversible visual loss. In Africa, glaucoma patients often present late, with very advanced disease.
A Ashaye, A Lam, A Lawan, AE Omoti, AM Agbeja-Baiyeroju, AP Rotchford, AT Giorgis, B Lundahl, BL Burke, Clare Gilbert, CT Ntim-Amponsah, DA Lee, DT La, G Smedslund, H Waterman, HA Quigley, J Lacey, JD Verrey, Jennifer Evans, Jim McCambridge, KP Balo, L Mitcheson, M Kroese, M Mafwiri, MC Leske, MM Abdull, Mohammed M Abdull, N Anand, PF Cook, PJ Foster, RA Charalel, RS Ramrattan, S Rollnick, S Vistamehr, SA Vernon, T Moyers, T Munder, T Wykes, TC Montreuil, The AGIS Investigators, WR Miller, WR Miller   +41 more
core   +3 more sources

Cell atlas of aqueous humor outflow pathways in eyes of humans and four model species provides insight into glaucoma pathogenesis

Proceedings of the National Academy of Sciences of the United States of America, 2020
Significance Glaucoma is a leading cause of irreversible blindness worldwide. A major risk factor is increased intraocular pressure (IOP), and all current treatment strategies for slowing disease progression center on IOP reduction.
Tavé van Zyl, Wenjun Yan, A. Mcadams, Yi-Rong Peng, K. Shekhar, A. Regev, D. Juric, J. Sanes   +7 more
semanticscholar   +1 more source

Structure-function relationships in glaucoma using enhanced depth imaging optical coherence tomography-derived parameters: a cross-sectional observational study

BMC Ophthalmology, 2019
Background To investigate structural and functional correlations in glaucoma patients using enhanced depth imaging spectral-domain optical coherence tomography (EDI OCT)-derived parameters.
Flavio S. Lopes, Igor Matsubara, Izabela Almeida, Syril K. Dorairaj, Roberto M. Vessani, Augusto Paranhos Jr, Tiago S. Prata   +6 more
doaj   +1 more source

Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: A crossover randomized clinical trial

Clinical and Experimental Ophthalmology, 2020
Retinal ganglion cells endure significant metabolic stress in glaucoma but maintain capacity to recover function. Nicotinamide, a precursor of NAD+, is low in serum of glaucoma patients and its supplementation provides robust protection of retinal ...
Flora Hui, Jessica Tang, Pete A. Williams, M. McGuinness, X. Hadoux, R. Casson, M. Coote, I. Trounce, K. Martin, P. van Wijngaarden, J. Crowston   +10 more
semanticscholar   +1 more source

Deep Learning for Optic Disc Segmentation and Glaucoma Diagnosis on Retinal Images

Applied Sciences, 2020
Glaucoma is a major global cause of blindness. As the symptoms of glaucoma appear, when the disease reaches an advanced stage, proper screening of glaucoma in the early stages is challenging.
Syna Sreng, Noppadol Maneerat, K. Hamamoto, Khin Yadanar Win   +3 more
semanticscholar   +1 more source

Primary open-angle glaucoma in patients with obstructive sleep apnoea in a Colombian population: a cross-sectional study

BMJ Open, 2023
Objective Determine the prevalence, functional and structural alterations of primary open-angle glaucoma (POAG) in patients with obstructive sleep apnoea (OSA).Design Cross-sectional.Setting Tertiary hospital associated with specialised center in ...
Maria Alejandra Cerquera Jaramillo, Sara Edith Moreno Mazo, Jeanneth Eloyne Toquica Osorio   +2 more
doaj   +1 more source

Visual field loss and vision-related quality of life in the Italian Primary Open Angle Glaucoma Study. [PDF]

, 2018
The aim of this study was to examine the relationship between visual field (VF) loss, vision-related quality of life (QoL) and glaucoma-related symptoms in a large cohort of primary open angle glaucoma (POAG) patients.
Galli, Fabio, Hollander, Lital, Italian Study Group on QoL in Glaucoma, Katsanos, Andreas, Oddone, Francesco, Poli, Davide, Quaranta, Luciano, Riva, Ivano, Rulli, Eliana, Torri, Valter, Weinreb, Robert N   +10 more
core   +2 more sources